PBSV (Pharma-Bio Serv) Forward Dividend Yield % : 0.00% (As of Jul. 19, 2025)

View and export this data going back to 2006. Start your Free Trial

What is Pharma-Bio Serv Forward Dividend Yield %?

As of today (2025-07-19), the Forward Annual Dividend Yield of Pharma-Bio Serv is 0.00%.

As of today (2025-07-19), the Trailing Annual Dividend Yield of Pharma-Bio Serv is 0.00%.

PBSV's Forward Dividend Yield % is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 2.375
* Ranked among companies with meaningful Forward Dividend Yield % only.

Pharma-Bio Serv's Dividends per Share for the three months ended in Apr. 2025 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Pharma-Bio Serv's Forward Dividend Yield %

For the Health Information Services subindustry, Pharma-Bio Serv's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma-Bio Serv's Forward Dividend Yield % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pharma-Bio Serv's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Pharma-Bio Serv's Forward Dividend Yield % falls into.

Save Embed

;

Save Embed

;

Pharma-Bio Serv Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Pharma-Bio Serv (OTCPK:PBSV) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Pharma-Bio Serv Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Pharma-Bio Serv's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma-Bio Serv Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharma-Bio Serv Inc (OTCPK:PBSV) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6 Road 696, Pharma-Bio Serv Building, Dorado, PRI, 00646

Website

https://www.pharmabioserv.com

Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies. It generates maximum revenue from Puerto Rico and also has its presence in United States, Europe and Other countries.

Executives

Elizabeth Plaza	10 percent owner	363 DORADO BEACH EAST, DORADO PR 00646
Altura Victor Sanchez	officer: President and CEO	C/O PHARMA-BIO SERV, INC., 6 ROAD 696, DORADO PR 00646
San Juan Holdings	10 percent owner	255 PONCE DE LEON, SUITE 305 MCS PLAZA, SAN JUAN PR 00917
Pedro J Lasanta	officer: Chief Financial Officer	373 MENDEZ VIGO, STE 110, DORADO PR 00646
Dov Perlysky	director	2 LAKESIDE DRIVE WEST, LAWRENCE NY 11559
L P Venturetek	10 percent owner	C/O DAVID SELENGUT ELLENOFF GROSSMAN, 370 LEXINGTON AVENUE 19TH FLOOR, NEW YORK NY 10017
Barron Partners Lp	10 percent owner	730 FIFTH AVENUE, 25TH FLOOR, NEW YORK NY 10019
Manuel O Morera	officer: Chief Financial Officer	373 MENDEZ VIGO, SUITE 110, DORADO PR 00646
Mark A Fazio	officer: Exec. Vice President and COO	P O BOX 1026 GREEN STREET, PERKASIE PA 18944
Kirk Wheeler Michel	director	209 EAST TRYON STREET, HILLSBOROUGH NC 27278
Irving L Wiesen	director	1273 NORTH AVENUE, APT 1E 7, NEW ROCHELLE NY 10804
Howard Spindel	director	39 BROADWAY SUITE 3300, NEW YORK NY 10028
Nelida Plaza Rodriguez	officer: Vice President and Secretary	G11 CALLE MADRE PERLA URB, DORADO DEL MAR, DORADO PR 00646
Krovim Llc	director, 10 percent owner, officer: Manager	P.O. BOX 339, LAWRENCE NY 11559